Polish biotechnology company Mabion S.A. signs an agreement with Novavax to start its commercial-scale production trials with U.S. pharmaceutical company for its future vaccine.
Polish biotechnology company Mabion S.A. signs an agreement with Novavax to begin commercial-scale production trials for Novavax's future vaccine.